Showing results (161-170 of 230) with videos related to
Sort By:
Pageof 23
Gynecologic Oncology|December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology studyUrsula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.International Journal of Cancer|November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancerAndrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAlexi A Wright, Angel Cronin, Dana E Milne, et al.The Lancet. Oncology|July 21, 2018
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trialAmit M Oza, Ursula A Matulonis, Susanne Malander, et al.The New England Journal of Medicine|June 13, 2019
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial CancerDaniela Matei, Virginia Filiaci, Marcus E Randall, et al.Gynecologic Oncology|March 9, 2025
Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcomaKevin Tyan, Kevin X Liu, Alicia C Smart, et al.Cell Reports|December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian CancerLiya Ding, Hye-Jung Kim, Qiwei Wang, et al.Gynecologic Oncology|August 11, 2020
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trialElizabeth K Lee, Niya Xiong, Su-Chun Cheng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian CancersFelipe Batalini, Doga C Gulhan, Victor Mao, et al.Gynecologic Oncology|January 15, 2019
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trialMichel Fabbro, Kathleen N Moore, Anne Dørum, et al.Pageof 23